List of Oral Presentations

 

The following Oral Presentations will be delivered at Cancer & Autoimmunity 2018:

Speaker Title Institution Country
Gerardo E. Guillén, PhD. Pending Title Center for Genetic Engineering and Biotechnology, CIGB Cuba
Silvio E. Perea, PhD Protein Kinase CK2 as emerging oncology target: Lessons from the CIGB-300 peptide inhibitor. Head of the Molecular Oncology Laboratory and Cancer Council at the CIGB Cuba
Yasser Perera, PhD

Targeting of Protein Kinase CK2-mediated phoshorylation in Acute Myeloid Leukemia (AML).

Molecular Oncology Laboratory. Cancer Department. Biomedical Research Area. CIGB Cuba
Andrew Sewell, PhD Pending Title Distinguished Research Professor and Wellcome Trust Senior Investigator, Infection & Immunity, Cardiff University School of Medicine, UK UK
Katherine Borden, PhD Targeting post-transcriptional regulation in cancer Principal Investigator, Structure and Function of the Cell Nucleus research unit, Institute for Research in Immunology and Cancer. Professor, Department of Pathology and Cell Biology, Faculty of Medicine, Université de Montréal, Canada. Canada
Renier J. Brentjens, MD, PhD Pending Title Memorial Sloan Kettering Cancer Center. Department of Medicine, Leukemia Service. New York. EE.UU
Jose R. Conejo-Garcia, MD, PhD Pending Title Chair, Department of Immunology. Moffitt Cancer Center, Tampa, USA EE.UU
Frank J. Rauscher, III, Ph.D Pending Title Caspar Wistar Professor and Founder, The Gene Expression and Regulation Program Wistar Professor, Department of Genetics, University of Pennsylvania, USA EE.UU